| [1] |
曹泽毅.中华妇产科学[M].第3版.北京:人民卫生出版社,2014:2632-2640.
|
| [2] |
CAO ZY. Chinese Obstetrics and Gynecology[M]. 3rd Edition. Beijing: People's medical publishing house, 2014: 2632-2640.
|
| [3] |
刘璐茜,张丹英,刘益群,等.多囊卵巢综合征的遗传学病因研究进展[J].辽宁中医药大学学报,2016,18(4):112-115.
|
| [4] |
LIU LQ, ZHANG DY, LIU YQ, et al. Research progress of genetic etiology of polycystic ovary syndrome[J]. J Liaoning Univ Tradit Chin Med, 2016, 18(4):112-115.
|
| [5] |
LI R, ZHANG Q,YANG D,et al. Prevalence of polycystic ovary syndrome in women in China: A large community-based study [J].Hum Reprod,2013,28(9):2562-2569.
|
| [6] |
张萍,滕香宇,王丽华,等.育龄护士多囊卵巢综合征流行病学调查研究[J].中华内分泌代谢杂志,2013,29(3):206-210.
|
| [7] |
ZHANG P, TENG XY, WANG LH, et al. The prevalence of polyocystic ovary syndrome in nurses of reproductive age[J]. Chin J Endocrinol Metab, 2013, 29(3):206-210.
|
| [8] |
中华医学会妇产科学分会内分泌学组.多囊卵巢综合征的诊断和治疗专家共识[J].中华妇产科杂志,2002, 4(7):553-555.
|
| [9] |
Endocrinology Group of Obstetrics and Gynecology Branch, Chinese Medical Association. Expert consensus on diagnosis and treatment of polycystic ovary syndrome[J]. Chin J Obstet Gynecol, 2002, 4(7):553-555.
|
| [10] |
LEGRO RS, ARSLANIAN SA,EHRMANN DA, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 2013, 98(12): 4565-4592.
|
| [11] |
中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:14-105.
|
| [12] |
Guideline for Clinical Trials of New Patent Chinese Medicines[M]. Beijing: China medical science and technology press, 2002:14-105.
|
| [13] |
国家中医药管理局.中医病证诊断疗效标准[M].北京:中国医药科技出版社,2011:62-63.
|
| [14] |
State Administration of Traditional Chinese Medicine. TCM Syndrome Diagnosis and Treatment Criteria[M].Beijing: China medical science and technology press, 2011:62-63.
|
| [15] |
张广美,周璐璐.中西医结合治疗多囊卵巢综合征的系统评价[J]. 中华中医药学刊,2012,30(7):1462-1464.
|
| [16] |
ZHANG GM, ZHOU LL. Systematic evaluation on polycystic ovary syndrome treated with integrating Chinese and western medicine[J]. Chin Arch Tradit Chin Med, 2012, 30(7):1462-1464.
|
| [17] |
张仲景.金匮要略[M].北京:人民卫生出版社,2005:61-62.
|
| [18] |
ZHANG ZJ. Essentials from the Golden Cabinet[M]. Beijing: Beijing publishing house, 2005:61-62.
|
| [19] |
太平惠民和剂局.太平惠民和剂局方[M].北京:人民卫生出版社,2007:134-135.
|
| [20] |
The Taiping Imperial Pharmacy. Beneficial Formulas from the Taiping Imperial Pharmacy[M]. Beijing: People's medical publishing house, 2007:134-135.
|
| [21] |
高建忠.读《内外伤辨惑论》[M].北京:中国中医药出版社,2015:86-88.
|
| [22] |
GAO JZ. Reading Clarifying Doubts about Damage from Internal and External Causes[M]. Beijing: China press of traditional Chinese medicine, 2015:86-88.
|
| [23] |
吴智春.金匮泻心汤抗动脉粥样硬化的实验研究[J].中国老年学杂志,2003,7(23):461-462.
|
| [24] |
WU ZC. Experimental study of Jinkui Xiexin decoction in anti-atherosclerosis[J]. Chin J Gerontol, 2003, 7(23):461-462.
|
| [25] |
舒适,刘小美.小檗碱对2型糖尿病大鼠IRS21/22 p85基因表达的影响[J].浙江中医杂志,2009,44(4):254-257.
|
| [26] |
SHU S, LIU XM. Effects of berberine on the expression of IRS21/22p85 gene in type 2 diabetic rats[J]. Zhejiang J Tradit Chin Med, 2009, 44(4):254-257.
|
| [27] |
杜宏,邵加庆.早期大黄酸干预对db/db小鼠胰岛功能的影响[J].南方医科大学学报,2011,31(9):1526-1530.
|
| [28] |
DU H, SHAO JQ. Effect of early intervention with rhein on islet function in db/db mice[J]. J Southern Med Univ, 2011, 31(9):1526-1530.
|